Literature DB >> 8001553

In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.

J T Stevens1, C Mapelli, J Tsao, M Hail, D O'Boyle, S P Weinheimer, C L Diianni.   

Abstract

Human cytomegalovirus (HCMV) encodes a protease that cleaves itself and the HCMV assembly protein. Two proteolytic processing sites within the protease were identified at Ala 256-Ser 257 (release site) and Ala 643-Ser 644 (maturation site). Identification of rP5-P4' and mP4-P6' as the minimal peptide substrates spanning the release and maturation cleavage sites, respectively, demonstrated a requirement for residues flanking the conserved core in substrate recognition and hydrolysis, which are unique to HCMV. Kinetic parameters determined for release-site-derived and maturation-site-derived peptides revealed a 10-fold increase in kcat/Km for a maturational peptide (mP4-P8') over release-site peptide (rP5-P5'). Experimental results with a panel of class-specific protease inhibitors were consistent with the protease being a member of the serine or cysteine family of proteases. Further investigation revealed that the HCMV protease activity decreased with incorporation of [14C]iodoacetic acid, but when approximately 4.5 mol 14C were incorporated/mol enzyme, the enzyme retained approximately 20% of its original activity, indicating that hydrolysis does not require a cysteine nucleophile. Analysis of diisopropyl-fluorophosphate-inactivated protease by mass spectrometry indicated a stoichiometry of 1 diisopropyl phosphate/protease molecule, suggesting that hydrolysis requires a single serine nucleophile. The residue modified by diisopropyl fluorophosphate was identified as Ser132 by modification with 3H-labeled diisopropyl fluorophosphate, peptide mapping and Edman degradation. This residue and the region in which it is found is highly conserved among the herpes virus proteases. These data demonstrates that HCMV protease is a serine protease and that Ser132 is the active-site nucleophile.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001553     DOI: 10.1111/j.1432-1033.1994.tb20060.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.

Authors:  Valérie Cottier; Alcide Barberis; Urs Lüthi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 3.  Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration.

Authors:  Ozlem Doğan Ekici; Mark Paetzel; Ross E Dalbey
Journal:  Protein Sci       Date:  2008-09-29       Impact factor: 6.725

4.  Independently cloned halves of cytomegalovirus assemblin, An and Ac, can restore proteolytic activity to assemblin mutants by intermolecular complementation.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 5.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

6.  Active residues and viral substrate cleavage sites of the protease of the birnavirus infectious pancreatic necrosis virus.

Authors:  S Petit; N Lejal; J C Huet; B Delmas
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics.

Authors:  R L LaFemina; K Bakshi; W J Long; B Pramanik; C A Veloski; B S Wolanski; A I Marcy; D J Hazuda
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Initial characterization of autoprocessing and active-center mutants of CMV proteinase.

Authors:  S W Snyder; R P Edalji; F G Lindh; K A Walter; L Solomon; S Pratt; K Steffy; T F Holzman
Journal:  J Protein Chem       Date:  1996-11

9.  Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions.

Authors:  Chee-Kai Chan; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Cloning, expression and characterization of the proteinase from human herpesvirus 6.

Authors:  N J Tigue; P J Matharu; N A Roberts; J S Mills; J Kay; R Jupp
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.